Sakar Healthcare Limited (SAKAR)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
158.45
0.55(0.35%)

Sakar Healthcare Limited researches, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of 155 formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins, as well as oncology drugs. The company also exports its products to approximately 53 countries, including South East Asia, Asia, Africa-Anglo and Francophone, MENA countries, America, and European markets. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Pricing Updates

TODAY'S HIGH

161.7

TODAY'S LOW

155.05

52 WEEK HIGH

161.7

52 WEEK LOW

56.9

Major Holders

% of Shares Held by
All Insider

nan

% of Shares Held by
Institutions

nan

% of Float Held by
Institutions

nan

Number of Institutions
Holding Shares

nan

Company Overview

MARKET CAP

247.46 Cr.

ETERPRISE VALUE

354.64 Cr.

NO. OF SHARES

1.56 Cr.

BOOK VALUE

74.462

DIV. YIELD

None%

DEBT

92.86 Cr.

GROSS PROFIT

53.79 Cr.

CASH

7.13 Cr.

REVENUE

128.22 Cr.

REVENUE/SHARE

73.743

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-7.09 Cr.-7.09 Cr.-7.09 Cr.-7.09 Cr.
Change To Liabilities10.81 Cr.2.59 Cr.1.11 Cr.-41.78 Lakhs
Total cashflows from Investing Activities-90.37 Cr.-46.83 Cr.-22.40 Cr.-24.90 Cr.
Net Borrowings47.84 Cr.26.05 Cr.5.20 Cr.-2.79 Cr.
Total Cash from Financing Activities54.62 Cr.32.03 Cr.3.48 Cr.8.77 Cr.
Other Liabilities-6.41 Cr.-51.54 Lakhs1.91 Cr.2.24 Cr.
Total Assets10.08 Cr.7.88 Cr.43.76 k13.19 Cr.
Net Income15.18 Cr.10.68 Cr.9.62 Cr.6.69 Cr.
Change in Cash-5.26 Lakhs-22.34 Lakhs-6.08 Lakhs44.88 k
Effect of Exchange Rate0000
Total Cash from Operating Activities35.69 Cr.14.57 Cr.18.86 Cr.16.14 Cr.
Depreciation9.66 Cr.8.05 Cr.7.07 Cr.6.03 Cr.
Other Cashflows from Investing Activities14.25 Cr.-11.28 Cr.-9.07 Cr.-9.07 Cr.
Dividends Paid0000
Change to Inventory1.51 Cr.-4.76 Cr.-4.07 Cr.-2.92 Cr.
Change to Account Receivables-1.81 Cr.-4.14 Cr.1.26 Cr.1.30 Cr.
Other Cashflows from Financing Activities-3.30 Cr.-1.90 Cr.-1.73 Cr.-1.63 Cr.
Change to Net Income6.71 Cr.2.66 Cr.1.93 Cr.3.19 Cr.
Capital Expenditures-97.53 Cr.-35.54 Cr.-12.97 Cr.-20.14 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax18.93 Cr.13.23 Cr.12.22 Cr.9.23 Cr.
Minority InterestNoneNoneNoneNone
Net Income19.65 Cr.15.12 Cr.13.60 Cr.11.38 Cr.
Selling General Administrative15.21 Cr.13.28 Cr.12.25 Cr.9.10 Cr.
Gross Profit53.79 Cr.43.78 Cr.40.17 Cr.33.22 Cr.
Ebit19.65 Cr.15.12 Cr.13.60 Cr.11.38 Cr.
Operating Income19.65 Cr.15.12 Cr.13.60 Cr.11.38 Cr.
Other Operating Expenses9.25 Cr.7.32 Cr.7.22 Cr.6.70 Cr.
Interest Expense-2.89 Cr.-2.33 Cr.-2.11 Cr.-2.05 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense3.75 Cr.2.55 Cr.2.60 Cr.2.54 Cr.
Total Revenue128.22 Cr.95.31 Cr.83.91 Cr.68.81 Cr.
Total Operating Expenses108.56 Cr.80.18 Cr.70.30 Cr.57.42 Cr.
Cost of Revenue74.42 Cr.51.52 Cr.43.74 Cr.35.58 Cr.
Total Other Income Expense Net-72.60 Lakhs-1.89 Cr.-1.37 Cr.-2.15 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.15.18 Cr.10.68 Cr.9.62 Cr.6.69 Cr.
Net Income Applicable to Common Shares15.18 Cr.10.68 Cr.9.62 Cr.6.69 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets073.01 Lakhs3.28 Cr.5.37 Cr.
Capital Surplus042.05 Cr.34.82 Cr.34.81 Cr.
Total Liabilities140.30 Cr.79.34 Cr.33.71 Cr.25.64 Cr.
Stock Holder Equity127.46 Cr.98.45 Cr.81.31 Cr.71.73 Cr.
Minority Interest0000
Other Liabilities8.35 Cr.21.90 Cr.5.41 Cr.4.50 Cr.
Total Assets267.76 Cr.177.79 Cr.115.03 Cr.97.38 Cr.
Common Stock17.11 Cr.15.61 Cr.14.96 Cr.14.96 Cr.
Retained Earnings040.93 Cr.31 Cr.21.37 Cr.
Other Liabilities8.53 Cr.7.62 Cr.7.09 Cr.6.54 Cr.
Good Will0000
Treasury Stock110.34 Cr.-15.55 Lakhs53.29 Lakhs57.50 Lakhs
Other Assets11.85 Cr.26.04 Cr.14.67 Cr.5.12 Cr.
Cash2.99 Lakhs8.24 Lakhs29.59 Lakhs36.67 Lakhs
Current Liabilities46.76 Cr.33.26 Cr.14.15 Cr.13.88 Cr.
Long Term Asset Charges0000
Short Long Term Debt3.33 Cr.2.45 Cr.1.96 Cr.3.16 Cr.
Other Stockholder Equity110.34 Cr.-15.55 Lakhs53.29 Lakhs57.50 Lakhs
Property Plant Equipment205.88 Cr.117.28 Cr.75.50 Cr.66.81 Cr.
Total Cur. Assets50.02 Cr.33.72 Cr.21.57 Cr.20.05 Cr.
Long Term Investments0000
Net Tangible Assets127.46 Cr.97.72 Cr.78.03 Cr.66.35 Cr.
Short Term Investments7.10 Cr.000
Net Receivables28.70 Cr.12.37 Cr.8.23 Cr.9.50 Cr.
Long Term Debt85 Cr.38.45 Cr.12.47 Cr.5.21 Cr.
Inventory14.18 Cr.15.76 Cr.11.05 Cr.6.90 Cr.
Accounts Payable30.50 Cr.7.19 Cr.4.60 Cr.3.48 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account